Press Releases

Unraveling the Genomic Mysteries with CD Genomics’ RIP-Seq Services

Driving Genomic Research Forward with Advanced CRISPR Sequencing by CD Genomics

PharmaKure announces epigenetics collaboration with Sheffield Hallam University to understand mechanisms of Alzheimer’s Diseases

New collaboration will enhance ability to identify those more at risk of developing brain diseases to enable earlier interventions

Pioneering Human Whole Genome PacBio SMRT Sequencing with CD Genomics

Unraveling the Genomic Mysteries with CD Genomics’ RIP-Seq Services

Pramana Joins Proscia Ready To Help Laboratories Realize More Value From Their Pathology Data

Paving the way to advance cancer research and diagnosis with enriched, high-quality DICOM images

Pioneering Human Whole Genome PacBio SMRT Sequencing with CD Genomics

PathAI Launches New Pathologist-Centric Features on AISight to Enable Efficient Case Review through Intelligent Case Prioritization and Real-Time Multi-Institutional Collaboration

PathAI, Inc., a leading AI-powered precision pathology company, today announced the availability of two new features on the AISight digital pathology image management system – an Intelligent Caselist and AISight Live.

Driving Genomic Research Forward with Advanced CRISPR Sequencing by CD Genomics

Creative Enzymes Proudly Unveils Its Cutting-Edge Product, Recombinant Human Hyaluronidase PH20

Creative Enzymes Rolls out Customized Solutions in Enzyme, Probiotic and Extract Blends

Backed by Leading Health Systems, Vale Health Launches at Vive 2024; Wellness Marketplace Platform Enables Self-Directed Access to Vetted Products

AVIA’s Generative AI Strategic Collaborative Highlights Six-Month Milestones And Outlines Next Steps For Pioneering Initiative

Huateng Pharma Introduces Semaglutide Side Chain

Huateng Pharma, a leading provider of high-quality pharmaceutical intermediates, is proud to unveil its latest breakthrough product: Semaglutide Side Chain. This innovative addition to Huateng Pharma's portfolio represents a significant milestone in pharmaceutical innovation, offering a range of compounds including AEEA-AEEA (CAS NO.: 1143516-05-5), SNAC (CAS NO.: 203787-91-1), tBuO-Ste-Glu(AEEA-AEEA)-OtBu (CAS NO.:1118767-16-0), and Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH (CAS NO.: 1662688-20-1).

Creative Proteomics Unveils Comprehensive Exosome Lipidomics Services

Creative Proteomics Enhances Research Capabilities with Urine Untargeted Metabolomics

Creative Proteomics Expands Its Epigenetics Portfolio with Advanced Histone PTMs Analysis Service

BioIVT Announces Expansive Fresh Leukopak Capability in Europe

Alfa Chemistry Expands Selection of Click Chemistry Reagents: DBCO, BCN, and Tetrazines Included

Biotium Expands Selection of Novel Nuclear Stains for Enhanced Multiplexing Flexibility for Microscopy and Flow Cytometry Applications

Biotium has announced the expansion of its NucSpot® Nuclear Stains lineup, offering unprecedented specificity and flexibility for nuclear counterstaining.